COS Collagen Solutions Plc

TIDMCOS

Collagen Solutions PLC

04 February 2019

4 February 2019

Collagen Solutions plc

("Collagen Solutions" or the "Company")

Visit from Local Constituency Member of Scottish Parliament

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that on Monday it hosted a visit from the Member of the Scottish Parliament for Glasgow Provan, Ivan McKee.

Collagen Solutions' global management team met with Mr. McKee to discuss the Company's opportunity for growth in the Life Sciences industry and its plans for growing the Scottish economy and creating high-value jobs in Mr. McKee's constituency. The Company also discussed the access to high quality talent from local universities and life sciences firms in the area that have been and will continue to be crucial to support anticipated growth.

Ivan McKee commented: "I was delighted to visit the Collagen Solutions headquarters and hear about the ambitious expansion plans the business has. It's great to see a truly innovative business with world leading technology exporting globally from their facility in Robroyston. I'll be doing all I can to help support their growth."

Jamal Rushdy, CEO, commented: "It was a pleasure to host Mr. McKee on Monday in our offices and manufacturing facility in Robroyston in Glasgow. It is always good to hear about the Scottish enthusiasm and expertise around Life Sciences and to see the support that the Scottish Government provide to encourage growth and support in the local economy."

Enquiries:

 
 Collagen Solutions Plc 
 Jamal Rushdy, CEO                                         Via Walbrook 
 Hilary Spence, CFO 
 
 Walbrook PR Ltd          Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Anna Dunphy                                         Mob: 07876 741 001 
 Helen Cresswell                                     Mob: 07841 917 679 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRABUGDDBUGBGCS

(END) Dow Jones Newswires

February 04, 2019 10:55 ET (15:55 GMT)

Collagen Solutions (LSE:COS)
Historical Stock Chart
From Mar 2024 to Apr 2024

Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2023 to Apr 2024